Trademark Overview
On Monday, March 3, 2025, a trademark application was filed for TRIFECTA CELL INFUSION with the United States Patent and Trademark Office. The USPTO has given the TRIFECTA CELL INFUSION trademark a serial number of 99064085. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, August 7, 2025. This trademark is owned by ImmunityBio, Inc.. The TRIFECTA CELL INFUSION trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical preparations and substances containing autologous or allogeneic cells for the treatment of human diseases in the nature of cancer, non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, and infectious diseases; biologics, namely, cell-derived preparations, cell therapies, monoclonal antibodies, cytokines, immune modulators, antibod...
